Polocaine-mpf

   
Google
 
Web NewDrugInformation.com

Polocaine-mpf


Drug - Polocaine-mpf
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Mepivacaine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 1.5%
The potency of the active ingredient(s), Mepivacaine Hydrochloride. May repeat for multiple part products.

Applicant - ASTRAZENECA
The firm name holding legal responsibility for Polocaine-mpf. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089408
The FDA assigned number to Polocaine-mpf. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Polocaine-mpf. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 1, 1986
The date Polocaine-mpf was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Polocaine-mpf. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Polocaine-mpf is in. Format is RX, OTC, DISCN.

Applicant Full Name - Astrazeneca Lp
The full name of the firm holding legal responsibility for the new application of Polocaine-mpf.

Polocaine-mpf